Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Zelensky Imposes New Sanctions, Includes Iranian CitizensCabometyx Cuts Neuroendocrine Tumor RiskShamakhi released another playerWho will dictate Armenia's election?Guyana Oil Boom and Growth StrainsQurban Qurbanov stays at Qarabag until 2029Land dispute in Zaqatala: "If you object, go"Elshad Guliyev: The Tournament Starts Now for UsHeavy rains in Dagestan destroy 100m gabion damWorld Cup favorites snub Mexico basesZelensky Imposes New Sanctions, Includes Iranian CitizensCabometyx Cuts Neuroendocrine Tumor RiskShamakhi released another playerWho will dictate Armenia's election?Guyana Oil Boom and Growth StrainsQurban Qurbanov stays at Qarabag until 2029Land dispute in Zaqatala: "If you object, go"Elshad Guliyev: The Tournament Starts Now for UsHeavy rains in Dagestan destroy 100m gabion damWorld Cup favorites snub Mexico bases
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#immunome

Latest news and interesting information about immunome.

Immunome presents phase 3 trial results for desmoid tumor drug
Today / 12:32
|
339

Immunome presents phase 3 trial results for desmoid tumor drug

Immunome announces phase 3 results for varegacestat in desmoid tumors: 84% reduction in progression risk, 56% objective response rate.

COMPANY →
0
Barclays Starts Oncology Biotechs with Positive Outlook
2026-05-28 15:00
|
257

Barclays Starts Oncology Biotechs with Positive Outlook

Barclays initiates coverage of Alpha Tau Medical, Cellectis, Immunome, and Sutro Biopharma with Overweight ratings.

STOCK MARKETS →
0
...